Notice of AGM and posting of Report & Accounts

RNS Number : 9079A

Immupharma PLC

04 June 2019

 

                                                                                                                                                          4 JUNE 2019

ImmuPharma PLC

("ImmuPharma" or the "Company")

Notice of AGM and posting of Report & Accounts

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2018, and the Notice of Annual General Meeting has been posted to shareholders.

These documents are available, in electronic form, for download on the Company's website www.immupharma.co.uk.

ImmuPharma's Annual General Meeting will be held on Thursday 27 June at 10:30am (BST) at the offices of: Capital Access Group, 107 Cheapside, London, EC2V 6DN.

For further information please contact: ImmuPharma PLC (www.immupharma.com) + 44 (0) 207 152 4080 Tim McCarthy, Chairman Dimitri Dimitriou, Chief Executive Officer Lisa Baderoon, Head of Investor Relations + 44 (0) 7721 413496 SPARK Advisory Partners Limited (NOMAD) Neil Baldwin Vassil Kirtchev Stanford Capital Partners (Joint Broker) Patrick Claridge, John Howes SI Capital (Joint Broker) Nick Emerson [phone] [phone] [phone]

 

 

END

 

 

DOCUORWRKOANRRR